What is CI's current stock price?

As of now, CI is trading at $270.89, with a daily change of +0.03%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CI Stock Analysis & IQ Rating | Cigna

CI

Cigna

$270.89

+$0.28 | +0.03%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

TopRated 01:38 PM

opens the day with a confident nod from RBC Capital, which maintained its Outperform rating and sees more than 70% upside ahead. For a healthcare operator navigating demand tailwinds, that’s a vote of confidence worth no...

CI Stock IQ

Login to see Cigna (CI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CI Target Price

Login to display

Strengths

CI Rewards

Earnings are forecast to grow

CI Rewards

Upgraded on attractively valued

CI Rewards

Trading below its fair value

CI Rewards

Outperform the market

Technical Indicators

CI Technical Indicators

MACD above signal line

Chart

$295.41 (-8.30%)

$296.86 (-8.75%)

$314.4 (-13.84%)

$330.07 (-17.93%)

1year

6month

3month

1month

CI Risk Level

CI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

CI Analysts Opinion

CI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CI Analysts Opinion

CI Analysts opinion is positive but there was a setback from the past 3 months

CI Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

33%

81%

CI Street Sentiment

CI Street Sentiment is extremely bullish and have positive views on the near-term outlook

CI Performance Sentiment

Sentiments overview associated with CI events and the stock performance.

79%

19%

Positive

Negative

38 out of 48
events present

9 out of 48
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$256.38

Resistance
Price

$244.41

Current Price Range

$305.31

Show methods +

CI Latest Analysis +

The Cigna Group (CI) Presents at UBS Global Healthcare Conference 2025 Transcript.

Wed Nov 12, 2025

$271.84 | +1.07%

Activity

The Cigna Group Named Top Dividend Stock With Insider Buying and 2.28% Yield (CI). In this series we look through the most recent Dividend Channel DividendRank report and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insiders view of

Mon Nov 10, 2025

$258.09 | -2.45%

Activity

Potential

Continuum Recovery Center of Colorado Selects the Janus Contingency Management Platform to Strengthen Addiction Treatment Services. ) a leading Janus platform from Contingency Management Innovations () to expand its evidence-based treatment programs.CRC delivers a full spectrum of outpatient services including Partial Hospitalization Programming Intensive Outpatient Programs (morning and evening sessions) group counseling individual therapy and Medication-Assisted Treatment. As an in-network pro

Thu Nov 6, 2025

$256.38 | -1.23%

Activity

Potential

Wells Fargo Maintains Cigna Group (CI) Equal-Weight Recommendation. Fintel reports that on November 5 2025 Wells Fargo maintained coverage of Cigna Group (NYSE:CI) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 42.02% Upside

Thu Nov 6, 2025

$256.38 | -1.23%

Potential

Rating

Cigna price target lowered to $330 from $370 at Goldman Sachs.

Wed Nov 5, 2025

$259.58 | -1.93%

Potential

JP Morgan Maintains Cigna Group (CI) Overweight Recommendation. Fintel reports that on November 4 2025 JP Morgan maintained coverage of Cigna Group (NYSE:CI) with a Overweight recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

Goldman Sachs Maintains Cigna Group (CI) Buy Recommendation. Fintel reports that on November 4 2025 Goldman Sachs maintained coverage of Cigna Group (NYSE:CI) with a Buy recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

TD Cowen Maintains Cigna Group (CI) Buy Recommendation. Fintel reports that on November 4 2025 TD Cowen maintained coverage of Cigna Group (NYSE:CI) with a Buy recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market. CI) it expects margin pressure within the pharmacy benefit services segment over the next two years. During its earnings call the company added that in Evernorth it expects operating income to be .The specialty and care services business is expected to grow income towards the higher end of its long-term growth target offset by a decline in pharmacy benefit services.Goldman Sachs on Tuesday reduced EPS estimates and lowered p

Tue Nov 4, 2025

$264.66 | +2.34%

Potential

Tuesday 11/4 Insider Buying Report: CI AJG. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Monday Cigna Groups CEO David Cordani made a $999916 purchase of CI buying

Tue Nov 4, 2025

$264.66 | +2.34%

Activity

Momentum

FAQ About CI Stock Insights

What is CI current stock price?

What are CI stock strengths?

What risks are associated with CI stock?

When is CI next earnings report?

What is CI market cap and volume?

What is CI's current Stock IQ?

Should I buy CI stock right now?

Is CI a Strong Buy right now?

What does a 'Strong Buy' rating mean for CI?

What does a 'Strong Sell' rating mean for CI?

What factors influence CI's Stock IQ?

Explore our CI Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CI Stock Strategies
Effective Risk Management

FIND US ON

Receive our CI Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CI

Cigna

Current Price

$270.89

+$0.28 | +0.03%

52W High

$ 350

MKT CAP

$ 72.36B

52W Low

$ 239.51

VOL

$ 2.65M

P/E Ratio

11.93

AVG VOL

$ 2.28M

RSI

45.03

TREND

Downtrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CI Rewards

Earnings are forecast to grow

CI Rewards

Upgraded on attractively valued

CI Rewards

Trading below its fair value

CI Rewards

Outperform the market

Technical Indicators

CI Technical Indicators

MACD above signal line

CI Stock IQ

Login to unlock Cigna (CI) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$295.41 (-8.30%)

$296.86 (-8.75%)

$314.4 (-13.84%)

$330.07 (-17.93%)

1year

6month

3month

1month

CI Analysts Opinion

CI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CI Analysts Opinion

CI Analysts opinion is positive but there was a setback from the past 3 months

CI Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

79%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

33%

81%

CI Street Sentiment

CI Street Sentiment is extremely bullish and have positive views on the near-term outlook

CI Risk Level

CI has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

CI Performance Sentiment

Sentiments overview associated with CI events and the stock performance.

79%

19%

Positive

Negative

38 out of 48
events present

9 out of 48
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$256.38

Resistance
Price

$244.41

Current Price Range

$305.31

Show methods +

CI Latest Analysis

TopRated 01:38 PM

opens the day with a confident nod from RBC Capital, which maintained its Outperform rating and sees more than 70% upside ahead. For a healthcare operator navigating demand tailwinds, that’s a vote of confidence worth no...

The Cigna Group (CI) Presents at UBS Global Healthcare Conference 2025 Transcript.

Wed Nov 12, 2025

$271.84 | +1.07%

Activity

The Cigna Group Named Top Dividend Stock With Insider Buying and 2.28% Yield (CI). In this series we look through the most recent Dividend Channel DividendRank report and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insiders view of

Mon Nov 10, 2025

$258.09 | -2.45%

Activity

Potential

Continuum Recovery Center of Colorado Selects the Janus Contingency Management Platform to Strengthen Addiction Treatment Services. ) a leading Janus platform from Contingency Management Innovations () to expand its evidence-based treatment programs.CRC delivers a full spectrum of outpatient services including Partial Hospitalization Programming Intensive Outpatient Programs (morning and evening sessions) group counseling individual therapy and Medication-Assisted Treatment. As an in-network pro

Thu Nov 6, 2025

$256.38 | -1.23%

Activity

Potential

Wells Fargo Maintains Cigna Group (CI) Equal-Weight Recommendation. Fintel reports that on November 5 2025 Wells Fargo maintained coverage of Cigna Group (NYSE:CI) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 42.02% Upside

Thu Nov 6, 2025

$256.38 | -1.23%

Potential

Rating

Cigna price target lowered to $330 from $370 at Goldman Sachs.

Wed Nov 5, 2025

$259.58 | -1.93%

Potential

JP Morgan Maintains Cigna Group (CI) Overweight Recommendation. Fintel reports that on November 4 2025 JP Morgan maintained coverage of Cigna Group (NYSE:CI) with a Overweight recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

Goldman Sachs Maintains Cigna Group (CI) Buy Recommendation. Fintel reports that on November 4 2025 Goldman Sachs maintained coverage of Cigna Group (NYSE:CI) with a Buy recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

TD Cowen Maintains Cigna Group (CI) Buy Recommendation. Fintel reports that on November 4 2025 TD Cowen maintained coverage of Cigna Group (NYSE:CI) with a Buy recommendation. Analyst Price Forecast Suggests 39.27% Upside

Wed Nov 5, 2025

$259.58 | -1.93%

Rating

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market. CI) it expects margin pressure within the pharmacy benefit services segment over the next two years. During its earnings call the company added that in Evernorth it expects operating income to be .The specialty and care services business is expected to grow income towards the higher end of its long-term growth target offset by a decline in pharmacy benefit services.Goldman Sachs on Tuesday reduced EPS estimates and lowered p

Tue Nov 4, 2025

$264.66 | +2.34%

Potential

Tuesday 11/4 Insider Buying Report: CI AJG. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Monday Cigna Groups CEO David Cordani made a $999916 purchase of CI buying

Tue Nov 4, 2025

$264.66 | +2.34%

Activity

Momentum

Discover CI Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CI. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CI Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CI Stock trends

CI Stock performance

CI Stock analysis

CI investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CI

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CI

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CI Stock Analysis & IQ Rating | Cigna

CI Stock IQ

CI Target Price

CI Risk Level

CI Analysts Opinion

CI Street Sentiment

CI Performance Sentiment

Technical Price Levels

Explore our CI Stock insights

Receive our CI Daily Alerts

CI Stock IQ

CI Street Sentiment

CI Risk Level

Technical Price Levels

Discover CI Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CI. We're here to help you make informed investment decisions today.

Receive our CI Daily Alerts

CI Runner Alarm